Company Filing History:
Years Active: 2003
Title: Péter Kótay Nagy: Innovator in Pharmaceutical Chemistry
Introduction
Péter Kótay Nagy is a notable inventor based in Vác, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the brain. His work has implications for the treatment of various neurological conditions.
Latest Patents
Péter Kótay Nagy holds a patent for "8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as AMPA/kainate receptor inhibitors." This patent describes a novel compound that possesses unique competitive AMPA/kainate antagonist properties. The compound, along with its pharmaceutically acceptable quaternary ammonium salts, is useful in the treatment of diseases where inhibition of the AMPA/kainate receptors may have a favorable effect. The complete description of the compound is detailed in the patent specification.
Career Highlights
Péter Kótay Nagy is associated with Egis Gyogyszergyar Rt., a prominent pharmaceutical company in Hungary. His work at Egis has allowed him to focus on innovative drug development, contributing to advancements in medical treatments.
Collaborations
Throughout his career, he has collaborated with notable colleagues such as László Balázs and József Barkóczy. These collaborations have fostered a productive environment for research and development in pharmaceutical sciences.
Conclusion
Péter Kótay Nagy is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of neurological diseases. His innovative approach and collaboration with other experts in the field highlight the importance of teamwork in scientific advancements.